Shanmugam Muthusamy

Average Profitability
24.75%
Insider Buys Quantity
1
Insider Buys Sum
$138,251.50
Insider Sells Quantity
56
Insider Sells Sum
$41.35M

Insider Activity of Shanmugam Muthusamy

According to the SEC Form 4 filings, Shanmugam Muthusamy, being in a position of

  1. HEAD OF R&D, COO-NOVITIUM OPS at ANI Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 400000 shares for $23.98M,
    over all time since 2022-03-17, has bought 5000 shares for $138,252, and sold 700000 shares for $41.35M.

The largest purchase of all time was on 2022-03-17 and amounted to 5000 shares of ANI Pharmaceuticals, Inc. for $138,252.

The largest sale of all time was on 2023-08-14 and amounted to 27890 shares of ANI Pharmaceuticals, Inc. for $1.71M.

Biography of Shanmugam Muthusamy

No biography is available at this moment.

2024-07-18SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF R&D, COO-NOVITIUM OPS
2,743
0.0132%
$62.00$170,066-2.75%
2024-07-17SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF R&D, COO-NOVITIUM OPS
14,257
0.0682%
$63.16$900,472-5.26%
2024-07-16SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF R&D, COO-NOVITIUM OPS
22,000
0.103%
$64.27$1.41M-7.08%
2024-07-15SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF R&D, COO-NOVITIUM OPS
11,000
0.0508%
$63.38$697,1800%
2024-06-21SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF R&D, COO-NOVITIUM OPS
20,000
0.0866%
$58.90$1.18M+2.65%
2024-06-20SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF R&D, COO-NOVITIUM OPS
11,447
0.0503%
$59.86$685,217+1.15%
2024-06-18SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF R&D, COO-NOVITIUM OPS
10,607
0.0474%
$60.76$644,481-1.12%
2024-06-17SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF R&D, COO-NOVITIUM OPS
7,946
0.0359%
$61.41$487,964-2.77%
2024-05-20SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF R&D, COO-NOVITIUM OPS
12,855
0.0614%
$61.81$794,568-1.05%
2024-05-17SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF R&D, COO-NOVITIUM OPS
5,836
0.0269%
$62.09$362,357-0.64%
2024-05-16SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF R&D, COO-NOVITIUM OPS
16,459
0.078%
$63.84$1.05M-4.22%
2024-05-15SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF R&D, COO-NOVITIUM OPS
14,850
0.0719%
$65.86$978,021-5.71%
2024-04-19SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF R&D, COO-NOVITIUM OPS
16,809
0.0797%
$65.17$1.1M-5.71%
2024-04-18SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF R&D, COO-NOVITIUM OPS
10,423
0.05%
$64.98$677,287-4.35%
2024-04-17SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF R&D, COO-NOVITIUM OPS
9,520
0.0451%
$65.40$622,608-5.68%
2024-04-16SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF R&D, COO-NOVITIUM OPS
5,834
0.028%
$66.20$386,211-5.79%
2024-04-15SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF R&D, COO-NOVITIUM OPS
7,414
0.0352%
$66.33$491,771-6.63%
2024-03-08SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF R&D, COO-NOVITIUM OPS
10,000
0.0474%
$67.17$671,700-6.23%
2024-03-07SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF R&D, COO-NOVITIUM OPS
15,085
0.0714%
$66.35$1M-4.96%
2024-03-06SaleANI Pharmaceuticals, Inc.
ANIP
HEAD OF R&D, COO-NOVITIUM OPS
14,822
0.0727%
$65.47$970,396-3.74%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.